Published in Am J Kidney Dis on December 01, 1998
Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med (2002) 1.47
Trends in mortality and graft failure for renal transplant patients. CMAJ (2002) 0.77
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis (1998) 7.79
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol (2001) 4.36
Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med (1989) 3.67
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Delayed graft function: risk factors and implications for renal allograft survival. Transplantation (1997) 3.01
Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr (2002) 2.96
Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant (2001) 2.94
Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int (2001) 2.92
Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int (2006) 2.85
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis (2000) 2.65
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. Am J Transplant (2008) 2.38
Occupational and other exposures associated with male end-stage renal disease: a case/control study. Am J Public Health (1990) 2.26
Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis (1998) 2.16
Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol (2000) 2.16
Predictors of type of vascular access in hemodialysis patients. JAMA (1996) 2.00
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
The dose of hemodialysis and patient mortality. Kidney Int (1996) 1.82
Competition and efficiency in the end stage renal disease program. J Health Econ (1983) 1.79
Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis (1998) 1.78
Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Health Serv Res (1999) 1.78
Geographic variability in access to primary kidney transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.77
Socioeconomic status and end-stage renal disease in the United States. Kidney Int (1994) 1.75
The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant (1997) 1.73
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Survival analysis of patients undergoing dialysis. JAMA (1987) 1.53
Effect of race on access to recombinant human erythropoietin in long-term hemodialysis patients. JAMA (1994) 1.51
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation (2001) 1.46
Patterns of low incidence of treated end-stage renal disease among the elderly. Am J Kidney Dis (1992) 1.45
Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders. Q J Med (1989) 1.43
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Hemodialysis vascular access morbidity in the United States. Kidney Int (1993) 1.41
Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41
Causes of death in dialysis patients: racial and gender differences. J Am Soc Nephrol (1994) 1.40
Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol (2001) 1.40
Using USRDS generated mortality tables to compare local ESRD mortality rates to national rates. Kidney Int (1992) 1.38
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35
Association of gender and access to cadaveric renal transplantation. Am J Kidney Dis (1997) 1.33
Containing Medicaid costs in an era of growing physician supply. Health Care Financ Rev (1985) 1.33
Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int (1973) 1.32
Vascular access survival among incident hemodialysis patients in the United States. Am J Kidney Dis (1997) 1.29
Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int (1996) 1.27
The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26
Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med (1984) 1.25
Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int (1999) 1.25
Differences in survival between black and white patients with diabetic end-stage renal disease. Diabetes Care (1994) 1.23
Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis (1990) 1.21
Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest (1990) 1.20
Trends in organ donation and transplantation in the United States, 1998-2007. Am J Transplant (2009) 1.18
Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol (1990) 1.17
Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. Am J Kidney Dis (2001) 1.17
Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int (1996) 1.17
The Medicare cost of renal dialysis. Evidence from a statistical cost function. Med Care (1992) 1.17
Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int (1992) 1.17
Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am J Kidney Dis (1994) 1.16